Medical Health & Life Science Research News

New study: Lyme disease vaccine pipeline therapeutics product market H2 2017

Lyme Disease Vaccine Pipeline Therapeutics Product Market H2 2017 provides Lyme Disease vaccine development including key pharmaceutical companies Lyme Disease Pipeline project with Development Milestones. Valneva Receives FDA and European Approvals to Start Clinical Testing of Lyme Disease Vaccine Candidate.

- Agency -.

Lyme Disease Vaccine Pipeline Therapeutics Product Market H2 2017 latest report on pipeline product development with descriptive Lyme disease drugs profiles, therapeutics development provides comprehensive information on the therapeutics development for Lyme Disease complete with analysis by stage of development Lyme Disease drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The pipeline guide provides a snapshot of the global therapeutic landscape of Lyme disease (Infectious Disease) and covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. Report helps you to find and recognize significant and varied types of therapeutics under development for Lyme disease (Infectious Disease).

- Agency -.

Get Report www.reportsnreports.com/contacts/discount.aspx?name=1132627.

Companies involved in Lyme Disease Therapeutics Development Analyzed are LondonPharma Ltd, NovoBiotic Pharmaceuticals LLC, Valneva SE.

The pipeline guide features descriptive Lyme Disease drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The Lyme disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme disease and features dormant and discontinued projects.

The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 2, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecule respectively.

Report encapsulates all the dormant and discontinued pipeline projects also reviews latest news related to pipeline therapeutics for Lyme disease (Infectious Disease)

Lyme Disease Vaccine and Drug Research and Development analysed in Report are Azithromycin, lyme disease vaccine, lyme disease vaccine 2, Monoclonal Antibody to Inhibit CRASP1 for Lyme Disease, Small Molecule for Lyme Disease, Small Molecules for Lyme Disease, VLA-15.

Access This Report at www.reportsnreports.com/purchase.aspx?name=1132627 .

Lyme disease (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

List of Tables:

Number of Products under Development for Lyme disease, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Products under Development by Companies, H2 2017

Products under Development by Universities/Institutes, H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Lyme disease - Pipeline by LondonPharma Ltd, H2 2017

Lyme disease - Pipeline by NovoBiotic Pharmaceuticals LLC, H2 2017

Lyme disease - Pipeline by Valneva SE, H2 2017

Lyme disease - Dormant Projects, H2 2017

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.